Impacto de una intervención farmacéutica en la prevención de recaídas en depresión en atención primaria

Rubio-Valera, María; Peñarrubia-María, Maria Teresa; Fernández‐Vergel, Rita; Tejadillo, Andrea Cecilia Carvajal; Sánchez, Ana Fernández; Aznar-Lou, Ignacio; March-Pujol, Marian; Serrano‐Blanco, Antoni

doi:10.1016/j.aprim.2015.05.009

Cited by 4 publications

(1 citation statement)

References 25 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are many approaches to address adherence issues in patients with depression, such as collaborative care, [21][22][23][24][25][26][27][28][29][30][31][32][33] counseling, 34,35 cognitive-behavioral approaches, [36][37][38][39][40][41][42][43] psycho-education, 37,[44][45][46][47][48] support, 34,35,[49][50][51][52][53][54] coaching, 55,56 and shared decision-making skills training. 57,58 However, these approaches are only effective to improve short-term adherence but insufficient to appreciate long-term effect.…”

Section: Introductionmentioning

confidence: 99%

<p>Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders - MAPDep: a study protocol for a cluster randomized controlled trial</p>

Pino-Sedeño

Castro

Cuevas

et al. 2019

PPA

View full text Add to dashboard Cite

Purpose: Depression is a widespread mental disorder which can be treated effectively. However, low adherence to antidepressants is very common. The study of medication adherence in depression (MAPDep study) assesses the effectiveness and cost-effectiveness of a multicomponent strategy to enhance adherence toward medications in patients with depression. Intervention: The intervention is a multicomponent one consisting of an educational program for psychiatrists and/or a collaborative care program for patients and relatives, plus a reminder system that works through the use of an already available high-quality medication reminder application. Study design: MAPDep study is an open, multicenter, four-arm cluster randomized controlled trial. The clusters are mental health units where psychiatrists are invited to participate. The clusters are randomly allocated to one of the three interventions or to usual care (control arm). Patients (18-65 years of age) diagnosed with depressive disorder, those taking antidepressant medication for an existing diagnosis of depression, and mobile phone users are selected. In group 1, only patients and relatives receive intervention; in group 2, only psychiatrists receive intervention; and in group 3, patients/relatives and psychiatrists receive intervention. The primary outcome is adherence to the antidepressant drug. The calculated sample size is 400 patients. To examine changes across time, generalized linear mixed model with repeated measures will be used. A cost-effectiveness analysis will be conducted. The effectiveness measure is qualityadjusted life years. Deterministic sensitivity analyses are planned. Conclusion: MAPDep study aims to assess a multicomponent strategy to improve adherence toward medications in patients with depression, based not only on clinical effectiveness but also on cost-effectiveness. This methodology will enhance the transferability of the expected results beyond mental health services (patients and psychiatrists) to health care policy decision making. Clinical trial identifier: NCT03668457.

show abstract